Citigroup’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $151K | Sell |
|
|||||
|
2025
Q2 | $78.8K | Sell |
|
|||||
|
2025
Q1 | $269K | Sell |
|
|||||
|
2024
Q4 | $423K | Buy |
|
|||||
|
2024
Q3 | $274K | Buy |
|
|||||
|
2024
Q2 | $111K | Sell |
|
|||||
|
2024
Q1 | $956K | Sell |
|
|||||
|
2023
Q4 | $1.13M | Buy |
|
|||||
|
2023
Q3 | $14.6K | Sell |
|
|||||
|
2023
Q2 | $21.1K | Sell |
|
|||||
|
2023
Q1 | $63.5K | Buy |
|
|||||
|
2022
Q4 | $97.6K | Buy |
|
|||||
|
2022
Q3 | $87K | Buy |
|
|||||
|
2022
Q2 | $32K | Buy |
|
|||||
|
2022
Q1 | $16K | Sell |
|
|||||
|
2021
Q4 | $73K | Buy |
|
|||||
|
2021
Q3 | $61K | Sell |
|
|||||
|
2021
Q2 | $3.24M | Sell |
|
|||||
|
2021
Q1 | $4.63M | Buy |
|
|||||
|
2020
Q4 | $288K | Sell |
|
|||||
|
2020
Q3 | $634K | Sell |
|
|||||
|
2020
Q2 | $2.3M | Buy |
|
|||||
|
2020
Q1 | $1.03M | Buy |
|
|||||
|
2019
Q4 | $1.46M | Sell |
|
|||||
|
2019
Q3 | $3.79M | Sell |
|
|||||
|
2019
Q2 | $6.97M | Buy |
|
|||||
|
2019
Q1 | $647K | Sell |
|
|||||
|
2018
Q4 | $11.1M | Buy |
|
|||||
|
2018
Q3 | $5.1M | Buy |
|
|||||
|
2018
Q2 | $735K | Sell |
|
|||||
|
2018
Q1 | $1.4M | Sell |
|
|||||
|
2017
Q4 | $4.33M | Buy |
|
|||||
|
2017
Q3 | $1.43M | Sell |
|
|||||
|
2017
Q2 | $2.65M | Buy |
|
|||||
|
2017
Q1 | $756K | Buy |
|
|||||
|
2016
Q4 | $132K | Sell |
|
|||||
|
2016
Q3 | $201K | Buy |
|
|||||
|
2016
Q2 | $125K | Sell |
|
|||||
|
2016
Q1 | $415K | Sell |
|
|||||
|
2015
Q4 | $906K | Buy |
|
|||||
|
2015
Q3 | $504K | Sell |
|
|||||
|
2015
Q2 | $1.8M | Buy |
|
|||||
|
2015
Q1 | $1.25M | Sell |
|
|||||
|
2014
Q4 | $708K | Sell |
|
|||||
|
2014
Q3 | $473K | Buy |
|
|||||
|
2014
Q2 | $303K | Buy |
|
|||||
|
2014
Q1 | $284K | Sell |
|
|||||
|
2013
Q4 | $265K | Buy |
|
|||||
|
2013
Q3 | $200K | Buy |
|